Print

Highland Instruments, Inc. Announces Award of SBIR Grant for Clinical Evaluation of Non-Invasive Brain Stimulation Technologies  
7/31/2012 9:55:59 AM

BOSTON--(BUSINESS WIRE)--Highland Instruments, Inc., (“Highland”) today announced award of a multi-year SBIR Grant from the National Institutes of Health National Institute of Neurological Disorders and Stroke (“NIH-NINDS”) for the clinical evaluation of Highland’s ElectroSonic Stimulation (“ESStim™”) technology for the treatment of Parkinson’s Disease (“PD”)1. The main academic partner collaborator in this grant and location of the clinical trial will be Spaulding Rehabilitation (“Spaulding”) Hospital’s Laboratory of Neuromodulation (Boston). Felipe Fregni, MD, PhD, MPH, will be the Lead Clinical Investigator. Dr. Fregni is the Director of the Laboratory of Neuromodulation at Spaulding Rehabilitation Hospital and Assistant Professor of Neurology at Harvard Medical School.